Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Perimenopausal Bone Loss”

364 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 364 results

Post-approval studies (Phase 4)Study completedNCT00357331
What this trial is testing

The Effects of Potassium Citrate on Bone Metabolism

Who this might be right for
Bone Diseases, MetabolicOsteoporosis, Postmenopausal
Weill Medical College of Cornell University 83
Testing effectiveness (Phase 2)Study completedNCT00112437
What this trial is testing

Examine the Effects of an Experimental Drug on Postmenopausal Osteoporosis (MK-0822-004)

Who this might be right for
Osteoporosis
Merck Sharp & Dohme LLC 399
Testing effectiveness (Phase 2)Active Not RecruitingNCT06577935
What this trial is testing

A Trial Evaluating Efficacy of AGA2118 in PostMenopausal Women wIth Low Bone MasS (ARTEMIS)

Who this might be right for
Postmenopausal Osteoporosis
Angitia Biopharmaceuticals 379
Large-scale testing (Phase 3)Study completedNCT01495000
What this trial is testing

A Study in Indian Postmenopausal Women With Osteoporosis to Evaluate the Efficacy and Safety of Denosumab

Who this might be right for
Osteoporosis, Postmenopausal
GlaxoSmithKline 250
Large-scale testing (Phase 3)Study completedNCT01631214
What this trial is testing

Study to Determine the Efficacy and Safety of Romosozumab in the Treatment of Postmenopausal Women With Osteoporosis

Who this might be right for
Postmenopausal Women With Osteoporosis
Amgen 4,093
Large-scale testing (Phase 3)Study completedNCT00043719
What this trial is testing

Nitroglycerin Ointment for Preventing Bone Loss in Postmenopausal Women

Who this might be right for
OsteoporosisOsteopenia
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 200
Not applicableStudy completedNCT00578981
What this trial is testing

Osteoporosis Choice Decision Aid for Use of Bisphosphonates in Postmenopausal Women

Who this might be right for
OsteoporosisBone Loss, Age RelatedPostmenopausal Bone Loss+1 more
Mayo Clinic 100
Post-approval studies (Phase 4)Study completedNCT01535027
What this trial is testing

Combined Administration of Teripapartide and Antiresorptive Agents in Postmenopausal Osteoporosis

Who this might be right for
Osteoporosis
Medical University of Vienna 125
Not applicableLooking for participantsNCT07242612
What this trial is testing

Bone Turnover Markers and Treatment Efficacy in Postmenopausal Osteoporosis

Who this might be right for
OsteoporosisOsteoporosis, Postmenopausal
Khyber Medical University Peshawar 40
Not applicableStudy completedNCT03337971
What this trial is testing

Nutritional Supplement and Bone Health in Post-Menopausal Women

Who this might be right for
Bone and BonesOsteoporosis RiskOsteoporosis, Postmenopausal
University of Limerick 16
Not applicableStudy completedNCT04169789
What this trial is testing

Prevention of Early Postmenopausal Bone Loss With Lactobacillus Reuteri

Who this might be right for
Postmenopausal Osteoporosis
Sahlgrenska University Hospital 239
Post-approval studies (Phase 4)UnknownNCT04719650
What this trial is testing

Clinical Pharmacokinetics and Pharmacodynamics Study of Different Doses of Zoledronic Acid

Who this might be right for
Postmenopausal Osteoporosis
Peking University Third Hospital 64
Post-approval studies (Phase 4)Study completedNCT00503113
What this trial is testing

Bonviva (Ibandronate) and Alendronate on Renal Function in Postmenopausal Women With Osteoporosis at High Risk for Renal Disease.

Who this might be right for
Post-Menopausal Osteoporosis
Hoffmann-La Roche 801
Not applicableStudy completedNCT01881204
What this trial is testing

Hesperidin and Bone Health in Postmenopausal Women

Who this might be right for
Osteoporosis, Postmenopausal
Purdue University 12
Large-scale testing (Phase 3)Study completedNCT05087030
What this trial is testing

Comparative Efficacy and Safety Study of RGB-14-P and Prolia® in Women With Postmenopausal Osteoporosis

Who this might be right for
Postmenopausal Osteoporosis
Gedeon Richter Plc. 473
Testing effectiveness (Phase 2)Study completedNCT00896532
What this trial is testing

Romosozumab (AMG 785) in Postmenopausal Women With Low Bone Mineral Density

Who this might be right for
Low Bone Mineral DensityPostmenopausal Osteoporosis
Amgen 419
Testing effectiveness (Phase 2)Study completedNCT00533650
What this trial is testing

Proof of Concept (Bone Resorption/Bone Mineral Density) Study (0429-005)

Who this might be right for
Post-Menopausal Osteoporosis
Merck Sharp & Dohme LLC 227
Not applicableLooking for participantsNCT07120997
What this trial is testing

Prunes Preventing Bone Loss in Perimenopause

Who this might be right for
Perimenopausal Bone Loss
Penn State University 124
Post-approval studies (Phase 4)UnknownNCT05402852
What this trial is testing

Effectiveness and Safety of EuBone® Capsules for Bone Health in Postmenopausal Women

Who this might be right for
Osteoporosis, Postmenopausal
Shandong University 30
Post-approval studies (Phase 4)Study completedNCT00927186
What this trial is testing

Effects of Teriparatide or Zoledronic Acid Treatment on Bone in Postmenopausal Osteoporotic Women

Who this might be right for
Osteoporosis, Post-menopausal
Eli Lilly and Company 69
Load More Results